Literature DB >> 6690472

Concurrent sickle cell anemia and alpha-thalassemia. Effect on pathological properties of sickle erythrocytes.

S H Embury, M R Clark, G Monroy, N Mohandas.   

Abstract

The concurrence of sickle cell anemia and alpha-thalassemia results in less severe hemolytic anemia apparently as a result of reduced intraerythrocytic concentration of hemoglobin S and its retarded polymerization. We have evaluated the effect of alpha-globin gene number on several interrelated properties of sickle erythrocytes (RBC) that are expected to correlate with the hemolytic and rheologic consequences of sickle cell disease. The irreversibly sickled cell number, proportion of very dense sickle RBC, and diminished deformability of sickle RBC each varied directly with alpha-globin gene number. Sickle RBC density was a direct function of the mean corpuscular hemoglobin concentration (MCHC). Even in nonsickle RBC, alpha-globin gene number varied directly with RBC density. Despite differences in alpha-globin gene number, sickle RBC of the same density had the same degree of deformability and dehydration. These data indicate that the fundamental effect of alpha-thalassemia is to inhibit the generation of sickle RBC having high density and MCHC, and that the other beneficial effects of sickle RBC are secondary to this process. The less consistent effect on overall clinical severity reported for subjects with this concurrence may reflect an undefined detrimental effect of alpha-thalassemia, possibly on the whole blood viscosity or on sickle RBC membrane-mediated adherence phenomena.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6690472      PMCID: PMC424978          DOI: 10.1172/JCI111181

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

Review 1.  Fetal haemoglobin in homozygous sickle cell disease.

Authors:  G R Serjeant
Journal:  Clin Haematol       Date:  1975-02

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Isolation and partial characterization of a high molecular weight red cell membrane protein complex normally removed by the spleen.

Authors:  S E Lux; K M John
Journal:  Blood       Date:  1977-10       Impact factor: 22.113

Review 4.  Sickle-cell anemia: molecular and cellular bases of therapeutic approaches (first of three parts).

Authors:  J Dean; A N Schechter
Journal:  N Engl J Med       Date:  1978-10-05       Impact factor: 91.245

5.  Kinetics and mechanism of deoxyhemoglobin S gelation: a new approach to understanding sickle cell disease.

Authors:  J Hofrichter; P D Ross; W A Eaton
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

6.  Irreversible deformation of the spectrin-actin lattice in irreversibly sickled cells.

Authors:  S E Lux; K M John; M J Karnovsky
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

7.  Insertion of synthetic copies of human globin genes into bacterial plasmids.

Authors:  J T Wilson; L B Wilson; J K deRiel; L Villa-komaroff; A Efstratiadis; B G Forget; S M Weissman
Journal:  Nucleic Acids Res       Date:  1978-02       Impact factor: 16.971

8.  Abnormal rheology of oxygenated blood in sickle cell anemia.

Authors:  S Chien; S Usami; J F Bertles
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

9.  Monovalent cation composition and ATP and lipid content of irreversibly sickled cells.

Authors:  M R Clark; R C Unger; S B Shohet
Journal:  Blood       Date:  1978-06       Impact factor: 22.113

10.  Cation permeability alterations during sickling: relationship to cation composition and cellular hydration of irreversibly sickled cells.

Authors:  B E Glader; D G Nathan
Journal:  Blood       Date:  1978-05       Impact factor: 22.113

View more
  34 in total

1.  Prospective study of sickle cell trait and venous thromboembolism incidence.

Authors:  A R Folsom; W Tang; N S Roetker; A V Kshirsagar; V K Derebail; P L Lutsey; R Naik; J S Pankow; M L Grove; S Basu; N S Key; M Cushman
Journal:  J Thromb Haemost       Date:  2014-12-11       Impact factor: 5.824

2.  Realizing effectiveness across continents with hydroxyurea: Enrollment and baseline characteristics of the multicenter REACH study in Sub-Saharan Africa.

Authors:  Patrick T McGann; Thomas N Williams; Peter Olupot-Olupot; George A Tomlinson; Adam Lane; José Luís Reis da Fonseca; Robert Kitenge; George Mochamah; Ham Wabwire; Susan Stuber; Thad A Howard; Kathryn McElhinney; Banu Aygun; Teresa Latham; Brígida Santos; Léon Tshilolo; Russell E Ware
Journal:  Am J Hematol       Date:  2018-01-27       Impact factor: 10.047

3.  Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease.

Authors:  C T Noguchi; G J Dover; G P Rodgers; G R Serjeant; S E Antonarakis; N P Anagnou; D R Higgs; D J Weatherall; A N Schechter
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

4.  Density-based separation in multiphase systems provides a simple method to identify sickle cell disease.

Authors:  Ashok A Kumar; Matthew R Patton; Jonathan W Hennek; Si Yi Ryan Lee; Gaetana D'Alesio-Spina; Xiaoxi Yang; Julie Kanter; Sergey S Shevkoplyas; Carlo Brugnara; George M Whitesides
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-02       Impact factor: 11.205

5.  Analysis of crossover type in the alpha -3.7 haplotype among sickle cell anemia patients from various parts of Africa.

Authors:  C Dodé; A Berth; J Rochette; R Girot; D Labie
Journal:  Hum Genet       Date:  1988-02       Impact factor: 4.132

Review 6.  Knowledge insufficient: the management of haemoglobin SC disease.

Authors:  Lydia H Pecker; Beverly A Schaefer; Lori Luchtman-Jones
Journal:  Br J Haematol       Date:  2016-12-16       Impact factor: 6.998

7.  Measuring Deformability and Red Cell Heterogeneity in Blood by Ektacytometry.

Authors:  Nermi L Parrow; Pierre-Christian Violet; Hongbin Tu; James Nichols; Corinne A Pittman; Courtney Fitzhugh; Robert E Fleming; Narla Mohandas; John F Tisdale; Mark Levine
Journal:  J Vis Exp       Date:  2018-01-12       Impact factor: 1.355

8.  Biological impact of α genes, β haplotypes, and G6PD activity in sickle cell anemia at baseline and with hydroxyurea.

Authors:  Françoise Bernaudin; Cécile Arnaud; Annie Kamdem; Isabelle Hau; Françoise Lelong; Ralph Epaud; Corinne Pondarré; Serge Pissard
Journal:  Blood Adv       Date:  2018-03-27

Review 9.  Red cell membrane: past, present, and future.

Authors:  Narla Mohandas; Patrick G Gallagher
Journal:  Blood       Date:  2008-11-15       Impact factor: 22.113

Review 10.  Differences in the clinical and genotypic presentation of sickle cell disease around the world.

Authors:  Santosh L Saraf; Robert E Molokie; Mehdi Nouraie; Craig A Sable; Lori Luchtman-Jones; Gregory J Ensing; Andrew D Campbell; Sohail R Rana; Xiao M Niu; Roberto F Machado; Mark T Gladwin; Victor R Gordeuk
Journal:  Paediatr Respir Rev       Date:  2013-11-15       Impact factor: 2.726

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.